Guidelines for the management of hemophilia

Srivastava A, Brewer AK, Mauser-Bunschoten EP, Key NS, Kitchen S, Llinas A, Ludlam CA, Mahlangu JN, Mulder K, Poon MC, Street A and (2013). Guidelines for the management of hemophilia. Haemophilia. 19: e1-e47. https://doi.org/10.1111/j.1365-2516.2012.02909.x

Multi-stakeholder Approaches to Improve Evidence-Based Decisions in Rare Diseases: Engagement of Patients and Patient Organizations

Granados A, Mullin T, Moseley J, Meyer F, Avetisyan R, Wong-Rieger D, Kaatee M, Skinner M, Leyden S. Multi-stakeholder Approaches to Improve Evidence-Based Decisions in Rare Diseases: Engagement of Patients and Patient Organizations. Report of HTAi 2016 Panel Session. Health Technology Assessment International – Canada. (2016). Published at: http://www.htai.org 19 Sep 2016

Patient-relevant health outcomes for hemophilia care: development of an international standard outcomes set

van Balen EC, O’Mahony B, Cnossen MH, Dolan G, Blanchette VS, Fischer K, Gue D, O’Hara J, Iorio A, Jackson S, Konkle BA, Nugent DJ, Coffin D,  Skinner MW,  Smit C, Srivastava A, van Eenennaam F, van der Bom JG, Gouw SC. Patient-relevant health outcomes for hemophilia care: development of an international standard outcomes set. Res Pract Thromb Haemost. 2021;5:e12488. https://doi.org/10.1002/rth2.12488

The potential impact of gene therapy on health-related quality of life (HRQoL) domains in haemophilia

Bullinger M, Gardner D, Lewis H, Miesbach W, Nolte S, O’Hara J, O’Mahony B, Pollard D, Skinner M, Quinn J. The potential impact of gene therapy on health-related quality of life (HRQoL) domains in haemophilia. The Journal of Haemophilia Practice. 2021;8(1): 56-68. https://doi.org/10.17225/jhp00176